HER2/positive and HER2/low in inflammatory breast cancer recurrence.

Autor: Movchan OV; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Bagmut IY; Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine., Shipko AF; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Smolanka Senior II; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Sheremet MI; Department of Surgery No.1, Bukovinian State Medical University, Chernivtsi, Ukraine., Kolisnyk IL; Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine., Bagmut OV; Faculty of Computer Sciences, Karazin Kharkiv National University, Kharkiv, Ukraine., Lyashenko AO; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Loboda AD; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Ivankova OM; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Dosenko IV; National Cancer Institute, Ministry of Health, Kyiv, Ukraine., Lazaruk OV; Department of Pathology, Bukovinian State Medical University, Chernivtsi, Ukraine., Gyrla YV; Department of Surgery No.1, Bukovinian State Medical University, Chernivtsi, Ukraine., Bilookyi OV; Department of Surgery No.1, Bukovinian State Medical University, Chernivtsi, Ukraine.

Publikováno v: Journal of medicine and life [J Med Life] 2022 Dec; Vol. 15 (12), pp. 1573-1578.